Pharmaphorum interviews PAN CEO Kevin Hagan at Reuters Pharma USA 2023
Information about this website: Following the March 2026 merger of Patient Advocate Foundation and the PAN Foundation, this website is now a part of Patient Advocate Foundation and remains active during our website transition.
Where to find information during our transition:
- About the merged organization: uniting.patientadvocate.org
- Financial assistance: totalassist.org
- Additional direct patient services and resources: patientadvocate.org
- Education: panfoundation.org and education.patientadvocate.org
- Clinical trials education: clinicaltrials.panfoundation.org
- Advocacy: npaf.org
- Research: patientinsightinstitute.org
While the recent Medicare reforms included in the Inflation Reduction Act are an important step towards increasing healthcare access and affordability, many will continue to turn to charitable assistance foundations for financial support. During last month’s Reuters Pharma USA 2023 event, PAN’s President and CEO, Kevin L. Hagan, spoke with pharmaphorum’s editor-in-chief, Jonah Comstock, about the impact the recent Medicare reforms will have on patients and the important role of health equity more broadly.
